$0.00 EPS Expected for Sears Canada Inc. (SRSC); Protagonist Therapeutics (PTGX) Shorts Raised By 3.57%

June 7, 2017 - By Nellie Frank

Analysts expect Sears Canada Inc. (NASDAQ:SRSC) to report $0.00 EPS on June, 14. The stock decreased 3.59% or $0.033 on June 6, reaching $0.887. About shares traded. Sears Canada Inc. (NASDAQ:SRSC) has declined 69.54% since June 7, 2016 and is downtrending. It has underperformed by 86.24% the S&P500.

Protagonist Therapeutics Incorporated (NASDAQ:PTGX) had an increase of 3.57% in short interest. PTGX’s SI was 237,600 shares in June as released by FINRA. Its up 3.57% from 229,400 shares previously. With 10,500 avg volume, 23 days are for Protagonist Therapeutics Incorporated (NASDAQ:PTGX)’s short sellers to cover PTGX’s short positions. The SI to Protagonist Therapeutics Incorporated’s float is 3.35%. The stock decreased 0.85% or $0.09 during the last trading session, reaching $10.51. About shares traded. Protagonist Therapeutics Inc (NASDAQ:PTGX) has 0.00% since June 7, 2016 and is . It has underperformed by 16.70% the S&P500.

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical firm with a peptide technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs. The company has market cap of $175.83 million. The Company’s product pipeline includes PTG-100, PTG-200 and PTG-300. It currently has negative earnings. The Company’s primary focus is on developing oral peptide drugs that target biological pathways also targeted by marketed injectable antibody drugs.